Health VV116 Pharmacokinetics & Safety in Mild/Moderate Hepatic Impairment – COVID-19 Treatment by Dr Natalie Singh - Health Editor February 25, 2026 by Dr Natalie Singh - Health Editor February 25, 2026 Oral COVID-19 Treatment VV116 Shows Promise with Minimal Impact from Liver Impairment A new oral antiviral, VV116 (too known as mindeudesivir), is demonstrating encouraging results in clinical trials for the … 0 FacebookTwitterPinterestEmail